Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (HKG:9989)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
4.580
-0.010 (-0.22%)
Apr 3, 2025, 4:08 PM HKT

HKG:9989 Statistics

Total Valuation

HKG:9989 has a market cap or net worth of HKD 16.39 billion. The enterprise value is 17.51 billion.

Market Cap 16.39B
Enterprise Value 17.51B

Important Dates

The last earnings date was Saturday, March 29, 2025.

Earnings Date Mar 29, 2025
Ex-Dividend Date May 26, 2025

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) -0.00%
Shares Change (QoQ) +0.04%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 424.05M

Valuation Ratios

The trailing PE ratio is 23.82.

PE Ratio 23.82
Forward PE n/a
PS Ratio n/a
PB Ratio n/a
P/TBV Ratio 1.62
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 25.44
EV / Sales 3.12
EV / EBITDA 18.19
EV / EBIT 28.39
EV / FCF n/a

Financial Position

The company has a current ratio of 2.60, with a Debt / Equity ratio of 0.29.

Current Ratio 2.60
Quick Ratio 1.03
Debt / Equity 0.29
Debt / EBITDA 3.40
Debt / FCF n/a
Interest Coverage 5.09

Financial Efficiency

Return on equity (ROE) is 5.17% and return on invested capital (ROIC) is 2.70%.

Return on Equity (ROE) 5.17%
Return on Assets (ROA) 2.46%
Return on Invested Capital (ROIC) 2.70%
Return on Capital Employed (ROCE) 5.27%
Revenue Per Employee 2.91M
Profits Per Employee 357,344
Employee Count 2,080
Asset Turnover 0.29
Inventory Turnover 0.58

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +63.57% in the last 52 weeks. The beta is 0.51, so HKG:9989's price volatility has been lower than the market average.

Beta (5Y) 0.51
52-Week Price Change +63.57%
50-Day Moving Average 4.28
200-Day Moving Average 3.90
Relative Strength Index (RSI) 55.21
Average Volume (20 Days) 3,055,400

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, HKG:9989 had revenue of HKD 5.60 billion and earned 688.24 million in profits. Earnings per share was 0.47.

Revenue 5.60B
Gross Profit 1.85B
Operating Income 765.30M
Pretax Income 772.83M
Net Income 688.24M
EBITDA 1.11B
EBIT 765.30M
Earnings Per Share (EPS) 0.47
Full Income Statement

Balance Sheet

The company has 2.72 billion in cash and 3.77 billion in debt, giving a net cash position of -1.05 billion.

Cash & Cash Equivalents 2.72B
Total Debt 3.77B
Net Cash -1.05B
Net Cash Per Share n/a
Equity (Book Value) 12.99B
Book Value Per Share 8.81
Working Capital 6.30B
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 33.07%, with operating and profit margins of 13.67% and 12.30%.

Gross Margin 33.07%
Operating Margin 13.67%
Pretax Margin 13.81%
Profit Margin 12.30%
EBITDA Margin 19.83%
EBIT Margin 13.67%
FCF Margin n/a

Dividends & Yields

HKG:9989 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 0.00%
Shareholder Yield 0.00%
Earnings Yield 4.20%
FCF Yield n/a
Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a